Showing 611-620 of 2366 results for "".
Single Isolated Concussion Part I: Definitions, Classification, and Prognosis
https://practicalneurology.com/diseases-diagnoses/tbi/single-isolated-concussion-part-i-definitions-classification-and-prognosis/30268/Providing sound advice after a single isolated concussion.The Effects of Obesity on Brain Structure and Size
https://practicalneurology.com/diseases-diagnoses/headache-pain/the-effects-of-obesity-on-brain-structure-and-size/30714/An examination of both the pathophysiology of the link between obesity and brain injury, and available strategies that may reverse it.Oral Disease Modifying Therapy for MS: Important Considerations
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/oral-disease-modifying-therapy-for-ms-important-considerations/30827/The availability of an oral agent for MS may create a therapeutic dilemma for clinicians as they try to determine the role of new therapy in patient care.Diagnosis and Management of Neurodegenerative Atypical Parkinsonism
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-neurodegenerative-atypical-parkinsonism/30455/Monoclonal Antibodies and Migraine: What the Neurologist Needs to Know
https://practicalneurology.com/diseases-diagnoses/headache-pain/monoclonal-antibodies-and-migraine-what-the-neurologist-needs-to-know/30361/As a new age in headache medicine is set to begin, it is incumbent upon neurologists to become better familiarized with and explore the implications of monoclonal antibodies in patient care.The Approval of PFO Closure in the United States
https://practicalneurology.com/diseases-diagnoses/stroke/the-approval-of-pfo-closure-in-the-united-states/30295/A look back at the long road to FDA approval and the implications on patient care options going forward.Update on Treatment Options for Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/update-on-treatment-options-for-dementia/30528/Although there is no treatment to correct the pathological process that leads to AD, there is a large window of opportunity to treat this condition before it becomes clinically evident.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31019/Optimizing Restless Legs Syndrome Treatment: Insights from Recent Meta-Analysis and Clinical ExperiencesA recent meta-analysis evaluating the side effects and wearing-off effects of four Restless Legs Syndrome (RLS) medications highlighted significant findings relevant to clinical practice. The stud
- Second Opinionshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0505SecondOpinion-pdf/31458/Addressing the AD-VaD Diagnostic Challenge in NeurologyIn the debate surrounding Alzheimer’s Disease (AD) versus vascular dementia (VaD) diagnosis, Dr. Geldmacher’s April 2005 article, “Diagnosing Alzheimer’s: Easy Answers vs. Right Answers,” ignited significant discourse. Dr. Geldmacher critiques c
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31314/Persistent Cognitive Deficits Post-Motor Vehicle Accident: A Case Study and Insights on Malingering in Neurological PracticeA 35-year-old male, Mr. M., presented five months after sustaining a whiplash injury from a motor vehicle accident. Initially treated by his chiropractor, Dr. J., Mr. M. contin